PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

PET scans may allow early prediction of response to targeted therapy of thyroid cancer

2011-02-02
(Press-News.org) Reston, Va. (February 1, 2011) — Positron emission tomography (PET) can image metabolic changes following treatment with the protein kinase inhibitor vandetanib, helping to define the therapy response or the effectiveness of the therapeutic agent, according to research published in the February issue of The Journal of Nuclear Medicine. Currently being tested in clinical trials, vandetanib inhibits the function of the RET (rearranged-during-transfection protein) proto-oncogene and other protein kinases involved in the development and progression of cancer.

"For the most part, clinical trials have been measuring the effectiveness of vandetanib by changes in tumor size. Based on the activating effects of mutated RET and other protein kinases on numerous intracellular metabolic pathways, we hypothesized that PET imaging could play a role in the early evaluation of response to vandetanib," said Martin A. Walter, MD, lead author of the study "Metabolic Imaging Allows Early Prediction of Response to Vandetanib."

The study examined the usefulness of metabolic imaging to determine response to vandetanib in three ways. First, medullary thyroid cancer cells were used to create an in vitro model. After cultivation, the cells were treated with vandetanib, and changes in the metabolic profile of the cells were successfully monitored by transcriptional profiling and by radiotracer uptake studies.

Using the same untreated cells, the researchers then created an in vivo model by injecting mice with the cancerous cells and treating them with vandetanib. Small animal PET/computed tomography (CT) imaging was performed and was found to reproduce the in vitro findings of metabolic activity after three days.

Finally, a 43-year old patient with biopsy-proven metastasized medullary thyroid cancer was treated with vandetanib. PET scans taken at 12 and 24 weeks after treatment were able to detect metabolic response to vandetanib, consistent with the in vitro and in vivo samples.

"With the increasing number of available treatment options, careful patient selection is necessary to ensure targeted therapy is administered to those most likely to gain clinical benefit," said Walter. "The identification of markers of treatment efficacy is a key factor for the success of these novel treatment approaches."

"Furthermore," he continued, "relating in-vivo PET imaging metabolic data with transcriptional profiling data using cluster analysis is an innovative concept that allows much potential in the field of molecular imaging."

###

Authors of the scientific article, "Metabolic Imaging Allows Early Prediction of Response to Vandetanib" include: Martin A. Walter, Institute of Nuclear Medicine, University Hospital, Bern, Switzerland, and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, Calif.; Matthias R. Benz, Isabel J. Hildebrandt, Rachel E. Lang, Michael E. Phelps and Johannes, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, Calif.; Verena Hartung and Andreas Bockisch, Institute of Nuclear Medicine, University Hospital, Essen, Germany; Robert D. Damoiseaux, Molecular Shared Screening Resources, UCLA, Los Angeles, Calif.; and Wolfgang A. Weber, Department of Nuclear Medicine, University Hospital, Freiburg, Germany, and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, Calif.

Please visit the SNM Newsroom to view the PDF of the study. To schedule an interview with the researchers, please contact Susan Martonik at (703) 652-6773 or smartonik@snm.org. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.

About SNM—Advancing Molecular Imaging and Therapy

SNM is an international scientific and medical organization dedicated to raising public awareness about what molecular imaging is and how it can help provide patients with the best health care possible. SNM members specialize in molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated.

SNM's more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit http://www.snm.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Barrow TRPV1 research highlighted in Journal of Neuroscience

2011-02-02
(Phoenix, Arizona February 1, 2011) -- Research by a Barrow Neurological Institute scientist on the thermoregulatory effects of a receptor more commonly studied for its role in pain is the cover story in the Feb. 2 issue of the Journal of Neuroscience. The research was conducted by an international team led by Andrej Romanovsky, MD, PhD, Director of the Systemic Inflammation Laboratory (FeverLab), at Barrow, which is a part of St. Joseph's Hospital and Medical Center. The featured research discovers a new role of TRPV1 (transient receptor potential vanilloid-1) receptors ...

Gestures provide a helping hand in problem solving

2011-02-02
WASHINGTON — Talking with your hands can trigger mental images that help solve complex problems relating to spatial visualization, an important skill for both students and professionals, according to new research published by the American Psychological Association. Spatial visualization is the ability to mentally rotate or move an object to a different position or view. An air traffic controller uses spatial visualization to mentally track planes in the air based only on a two-dimensional radar screen. An interior decorator needs spatial visualization to picture how ...

Seeking social genes

2011-02-02
In order understand the evolution of complex societies, researchers are sequencing the genomes of social insects. The most recent data, published this week in the Early Edition of Proceedings of the National Academy of Sciences, come from several species of ants, including the red harvester ant, Pogonomyrmex barbatus. A team, lead by Arizona State University organismal and systems biology professor Juergen Gadau, sequenced one of the genomes and set out to decipher which genes might be responsible for defining which ants work and which ants reproduce in a red harvester ...

Home and away: Are invasive plant species really that special?

Home and away: Are invasive plant species really that special?
2011-02-02
Invasive plant species are a serious environmental, economic and social problem worldwide. Their abundance can lead to lost native biodiversity and ecosystem functions, such as nutrient cycling. Despite substantial research, however, little is known about why some species dominate new habitats over native plants that technically should have the advantage. A common but rarely tested assumption, say biologists, is that these plants behave in a special way, making them more abundant when introduced into communities versus native plants that are already there. If true, ...

NASA satellites capture data on monster winter storm affecting 30 states

NASA satellites capture data on monster winter storm affecting 30 states
2011-02-02
It has already been called one of the largest winter storms since the 1950s and it is affecting 30 U.S. states today with snow, sleet, freezing rain and rain. NASA satellites have gathering data on the storm that stretches from Texas and the Rockies to the New England states. NASA's Aqua and Terra satellites have been providing visible, infrared and microwave looks at the storm system's clouds, precipitation, temperatures and extent. Visible and infrared images and animations of the storm's clouds and movement are created every 15 minutes by the NASA GOES Project at ...

Transplanted human placenta-derived stem cells show therapeutic potential in stroke models

2011-02-02
Human amniotic epithelial cells, stem cells derived from human placenta left over from live births and generally discarded, proliferated and differentiated when they interacted with one kind of melatonin receptor, MT1. This potentially therapeutic response occurred when the stem cells were transplanted into laboratory test tube and animal models of stroke. The same cells did not perform similarly when interacting with melatonin receptor MT2. Researchers from the University of South Florida's Department of Neurosurgery and Brain Repair, and co-researchers in Brescia, ...

Study examines incident hepatitis C infection in HIV-infected men

2011-02-02
Hepatitis C is a leading cause of illness and death for individuals infected with both HIV and hepatitis C. Recent reports from around the world demonstrate that hepatitis C is emerging as a sexually transmitted infection among HIV-infected men who do not inject drugs. However, many HIV-infected men do not receive continued screening for hepatitis C throughout their HIV care. Hepatitis C symptoms often do not manifest themselves until the later stages of the illness, so people are not as likely to know that they have become infected and hence need further testing and ...

NASA satellites reveal heavy rains in dangerous Cyclone Yasi on its Australian approach

NASA satellites reveal heavy rains in dangerous Cyclone Yasi on its Australian approach
2011-02-02
Several NASA satellites have been monitoring the growth of powerful and massive Cyclone Yasi and providing data on clouds, rainfall and intensity to forecasters as it nears Queensland, Australia. NASA data shows where the heaviest rainfall is occurring, frigid temperatures at the top of its thunderstorms and the size of Yasi's eye. Tropical cyclone Yasi became much more powerful and was upgraded to a dangerous category fpur tropical cyclone on the Saffir Simpson scale on February 1, 2011. A Cyclone Warning is now in effect for Queensland, Australia for coastal areas ...

Tuning graphene film so it sheds water

2011-02-02
Windshields that shed water so effectively that they don't need wipers. Ship hulls so slippery that they glide through the water more efficiently than ordinary hulls. These are some of the potential applications for graphene, one of the hottest new materials in the field of nanotechnology, raised by the research of James Dickerson, assistant professor of physics at Vanderbilt. Dickerson and his colleagues have figured out how to create a freestanding film of graphene oxide and alter its surface roughness so that it either causes water to bead up and run off or causes ...

Targeted particle fools brain's guardian to reach tumors

Targeted particle fools brains guardian to reach tumors
2011-02-02
HOUSTON — A targeted delivery combination selectively crosses the tight barrier that protects the brain from the bloodstream to home in on and bind to brain tumors, a research team led by scientists from The University of Texas MD Anderson Cancer Center reported in the January issue of the Journal of Clinical Investigation. In experiments with mice, the researchers demonstrated that the targeted particles guide payloads to image tumors, treat tumors, or can potentially do both to monitor treatment as it occurs. Their findings open a new research avenue for detecting and ...

LAST 30 PRESS RELEASES:

Family Heart Foundation appoints Dr. Seth Baum as Chairman of the Board of Directors

New route to ‘quantum spin liquid’ materials discovered for first time

Chang’e-6 basalts offer insights on lunar farside volcanism

Chang’e-6 lunar samples reveal 2.83-billion-year-old basalt with depleted mantle source

Zinc deficiency promotes Acinetobacter lung infection: study

How optogenetics can put the brakes on epilepsy seizures

Children exposed to antiseizure meds during pregnancy face neurodevelopmental risks, Drexel study finds

Adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer

Scientists transform blood into regenerative materials, paving the way for personalized, blood-based, 3D-printed implants

Maarja Öpik to take up the position of New Phytologist Editor-in-Chief from January 2025

Mountain lions coexist with outdoor recreationists by taking the night shift

Students who use dating apps take more risks with their sexual health

Breakthrough idea for CCU technology commercialization from 'carbon cycle of the earth'

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Depression research pioneer Dr. Philip Gold maps disease's full-body impact

Rapid growth of global wildland-urban interface associated with wildfire risk, study shows

Generation of rat offspring from ovarian oocytes by Cross-species transplantation

Duke-NUS scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness

Compound metalens achieves distortion-free imaging with wide field of view

Age on the molecular level: showing changes through proteins

Label distribution similarity-based noise correction for crowdsourcing

The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050

Diabetes medication may be effective in helping people drink less alcohol

US over 40s could live extra 5 years if they were all as active as top 25% of population

Limit hospital emissions by using short AI prompts - study

UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research

Fayetteville police positive about partnership with social workers

Optical biosensor rapidly detects monkeypox virus

New drug targets for Alzheimer’s identified from cerebrospinal fluid

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment

[Press-News.org] PET scans may allow early prediction of response to targeted therapy of thyroid cancer